Evidence map›Paper›PMID 33686650›Full record

ArticleBritish journal of haematology2021

Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.

Sahba Shafiee, Pascal Gelebart, Mihaela Popa, Monica Hellesøy, Randi Hovland, Rakel Brendsdal Forthun, Jungwoo Lee, Kaoru Tohyama, Anders Molven, Biju Parekkadan and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Humanized mouse models in MDS.Cell death & disease · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sahba ShafieeDepartment of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.ORCID 0000-0001-8478-6140
Pascal GelebartDepartment of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.
Mihaela PopaKinN Therapeutics, Laboratory Building, Bergen University Hospital, Bergen, Norway.
Monica HellesøyKinN Therapeutics, Laboratory Building, Bergen University Hospital, Bergen, Norway.
Randi HovlandDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Rakel Brendsdal ForthunDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Jungwoo LeeDepartment of Chemical Engineering, Institute for Applied Life Sciences, University of Massachusetts, Massachusetts, USA.
Kaoru TohyamaDepartment of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan.
Anders MolvenGade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Biju ParekkadanDepartment of Biomedical Engineering, Rutgers University and the Department of Medicine, Rutgers Biomedical and Health Sciences, Piscataway, NJ, 08854, USA.
Bjørn Tore GjertsenDepartment of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.
Astrid Olsnes KittangDepartment of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.
Emmet McCormackDepartment of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.

Funding

Artificial, Humanized Stem Cell NichesR01EB012521 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI PAREKKADAN, BIJU · 2011 to 2021
$6.0M
NIBIB NIH HHS R01 EB012521
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, RefractoryAnimalsCell LineEpigenomicsHumansHydrogelsIn Situ Hybridization, FluorescenceMaleMiceMiddle AgedModels, AnimalMutationMyelodysplastic SyndromesXenograft Model Antitumor AssaysHydrogelshydrogel scaffoldMDS-LMDS-L-2007MDS-LGFmyelodysplastic syndromes (MDS)NSG miceNSGS micexenograft mouse model

Identifiers

PMID33686650
PMCPMC8112349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.